Delisted from NASDAQ in Aug 2023
Company logo

PTE - PolarityTE, Inc.

NASDAQ -> Healthcare -> Biotechnology
Salt Lake City, United States
Type: Equity

PTE price evolution
PTE
(in millions $) 31 Mar 2023 31 Jan 2023 30 Sep 2022 30 Jun 2022
Current assets
Cash $6.39 $11.45 $16.09 $20.52
Short term investments
Net receivables $0.45 $0.33 $0.1 $0.1
Inventory
Total current assets $8.93 $13.26 $18.49 $22.9
Long term investments
Property, plant & equipment $8.21 $8.68 $2.75 $4.22
Goodwill & intangible assets
Total noncurrent assets $9.12 $9.59 $3.66 $5.13
Total investments
Total assets $18.05 $22.85 $22.14 $28.03
Current liabilities
Accounts payable $1.71 $0.46 $1.9 $1.94
Deferred revenue
Short long term debt
Total current liabilities $2.17 $2.07 $2.8 $3.51
Long term debt $2.5 $0.04 $0.05 $0.06
Total noncurrent liabilities $3.46 $4.16 $2.4 $4.47
Total debt $2.5 $2.67 $0.05 $0.06
Total liabilities $5.63 $6.23 $5.2 $7.99
Shareholders' equity
Retained earnings -$520.47 -$516.23 -$515.64 -$512.24
Other shareholder equity
Total shareholder equity $12.42 $16.62 $16.94 $20.05
(in millions $) 31 Jan 2023 31 Dec 2021 31 Dec 2020 31 Dec 2019
Current assets
Cash $11.45 $19.38 $25.52 $10.22
Short term investments $19.02
Net receivables $0.33 $0.98 $3.82 $1.73
Inventory $0.88 $0.25
Total current assets $13.26 $22.39 $31.22 $32.49
Long term investments
Property, plant & equipment $8.68 $8.07 $13 $19.5
Goodwill & intangible assets $0.82 $1.01
Total noncurrent assets $9.59 $8.79 $14.29 $21.11
Total investments $19.02
Total assets $22.85 $31.18 $45.51 $53.6
Current liabilities
Accounts payable $0.46 $3.12 $4.15 $7.09
Deferred revenue $0.07 $0.17 $0.1
Short long term debt $2.06 $0.53
Total current liabilities $2.07 $4.71 $8.48 $10.06
Long term debt $0.04 $0.04 $2.99 $2.99
Total noncurrent liabilities $4.16 $7.22 $9.69 $4.62
Total debt $2.67 $0.04 $5.05 $3.52
Total liabilities $6.23 $11.93 $18.17 $14.68
Shareholders' equity
Retained earnings -$516.23 -$508.4 -$478.21 -$435.36
Other shareholder equity $0.07
Total shareholder equity $16.62 $19.24 $27.34 $38.92
(in millions $) 31 Mar 2023 31 Dec 2022 30 Sep 2022 30 Jun 2022
Revenue
Total revenue $0.07
Cost of revenue $0.13
Gross Profit -$0.05
Operating activities
Research & development $2.28 $2.56 $2.55 $3.08
Selling, general & administrative $2.46 $2.57 $2.69 $3.56
Total operating expenses $4.8 $1.36 $5.41 $6.68
Operating income -$4.8 -$1.36 -$5.41 -$6.73
Income from continuing operations
EBIT -$4.27 -$0.62 -$3.4 -$0.05
Income tax expense
Interest expense -$0.03 -$0.02 $0 $0.01
Net income
Net income -$4.24 -$0.59 -$3.4 -$0.07
Income (for common shares) -$4.24 -$0.59 -$3.4 -$0.07
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Revenue
Total revenue $0.81 $9.4 $10.13 $5.65
Cost of revenue $0.62 $4.32 $4.42 $2.48
Gross Profit $0.2 $5.09 $5.7 $3.17
Operating activities
Research & development $11.05 $14.18 $11.53 $16.4
Selling, general & administrative $15.03 $23.28 $36.28 $80.17
Total operating expenses $22.57 $38.77 $51.64 $96.57
Operating income -$22.37 -$33.69 -$45.94 -$93.39
Income from continuing operations
EBIT -$7.82 -$30.06 -$42.67 -$92.49
Income tax expense
Interest expense $0.01 $0.13 $0.18
Net income
Net income -$7.83 -$30.19 -$42.85 -$92.49
Income (for common shares) -$7.83 -$30.19 -$42.85 -$92.49
(in millions $) 31 Mar 2023 31 Dec 2022 30 Sep 2022 30 Jun 2022
Net income -$4.24 -$0.59 -$3.4 -$0.07
Operating activities
Depreciation $0.15 $0.28 $0.37 $0.4
Business acquisitions & disposals $2.33
Stock-based compensation $0.05 $0.27 $0.3 $0.53
Total cash flows from operations -$5.08 -$4.3 -$4.03 -$8.23
Investing activities
Capital expenditures $0.1 $0.06 $0.02 $0.16
Investments
Total cash flows from investing $0.1 $0.06 $0.02 $2.48
Financing activities
Dividends paid
Sale and purchase of stock $0 $7.83
Net borrowings -$0.07 -$0.09 -$0.42 -$0.41
Total cash flows from financing -$0.07 -$0.41 -$0.42 $7.36
Effect of exchange rate
Change in cash and equivalents -$5.05 -$4.65 -$4.42 $1.62
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net income -$7.83 -$30.19 -$42.85 -$92.49
Operating activities
Depreciation $1.51 $2.84 $3.26 $3.19
Business acquisitions & disposals $2.33
Stock-based compensation $1.86 $5.38 $7.26 $31.4
Total cash flows from operations -$22.6 -$22.63 -$37.75 -$56.65
Investing activities
Capital expenditures $0.22 -$0.1 -$1.34 -$2.77
Investments $18.97 -$12.84
Total cash flows from investing $2.54 -$0.1 $17.63 -$15.62
Financing activities
Dividends paid
Sale and purchase of stock $7.83 $16.61 $33.13 $28.7
Net borrowings -$0.01 -$0.58 $2.45 -$0.99
Total cash flows from financing $12.13 $16.58 $35.42 $26.81
Effect of exchange rate
Change in cash and equivalents -$7.93 -$6.15 $15.3 -$45.45
Fundamentals
Market cap $487.85K
Enterprise value -$3.41M
Shares outstanding 7.33M
Revenue $73.00K
EBITDA -$7.14M
EBIT -$8.34M
Net Income -$8.30M
Revenue Q/Q -100.00%
Revenue Y/Y -98.66%
P/E ratio -0.06
EV/Sales -46.73
EV/EBITDA 0.48
EV/EBIT 0.41
P/S ratio 6.68
P/B ratio 0.04
Book/Share 1.70
Cash/Share 0.87
EPS -$1.13
ROA -36.48%
ROE -50.31%
Debt/Equity 0.37
Net debt/EBITDA 0.11
Current ratio 4.11
Quick ratio 4.11